Kadensa Capital’s Confluent CFLT Stock Holding History

Kadensa Capital’s Portfolio CFLT Stock Details CFLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-388,792	Closed	-$11.5M	–	18
2023 Q3	$11.5M	Buy	+388,792	New	+$13M	2.27%	15

Other funds holding CFLT

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACM

Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Kadensa Capital's CFLT Position: Q4 2023 in Review

Kadensa Capital sold out of Confluent (CFLT) in Q4 2023, closing a stake of 388,792 shares — an estimated $11.5M sold.

Kadensa Capital first reported a position in CFLT in Q3 2023 and held it in 1 quarter. The position peaked at $11.5M in Q3 2023. 365 funds tracked by Wall St. Rank hold CFLT as of Q4 2023.

Kadensa Capital reported no remaining Confluent position as of Q4 2023 after selling out during the quarter.
Kadensa Capital sold 388,792 Confluent shares in Q4 2023, an estimated $11.5M.
Kadensa Capital first reported a position in Confluent in Q3 2023 and held it in 1 quarter.
Kadensa Capital's Confluent position peaked at $11.5M in Q3 2023.
365 funds tracked by Wall St. Rank held Confluent as of Q4 2023.

Based on Kadensa Capital's 13F filing for Q4 2023, filed 14 Feb 2024.